Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 1 year […]
Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns Overweight Rating from Cantor Fitzgerald theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Investment analysts at Zacks Research decreased their Q1 2024 earnings estimates for shares of Jazz Pharmaceuticals in a research note issued to investors on Wednesday, March 20th. Zacks Research analyst S. Ganoria now anticipates that the specialty pharmaceutical company will post earnings per share of $3.24 for […]
Truist Financial Reiterates Buy Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns Buy Rating from Needham & Company LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.